A new study reveals that patients receiving radiofrequency catheter ablation compared to traditional drug therapies for atrial fibrillation (AF), a contributing factor to heart failure, have significantly lower hospitalization and mortality rates. The findings are published in the New England Journal of Medicine. The study's lead author, cardiologist Nassir F. Marrouche, M.D., discusses the research and its implications.